Issues
Generic medicines are the backbone of the U.S. prescription drug market, supplying more than 9 out of every 10 prescriptions. And the availability of generic medicines overall is remarkably stable – even during challenges such as the COVID-19 pandemic.
Nonetheless, drug shortages, which hit crisis proportions between 2010 and 2011, can be a challenge for manufacturers, providers, and patients. Due to aggressive efforts by industry and the Food and Drug Administration (FDA), the incidence of shortages has declined, but recent reports suggest a rise in shortages in 2023.
To help raise awareness of the essentialness of generic medicines to patients and our healthcare system, join our industry’s 4GRxANTED campaign. The #4GRxANTED campaign asks people to record a video or share a story explaining who or what in their lives they take for granted but shouldn’t and post it on social media. For every video created, liked or shared with the hashtag #4GRxANTED, the generics industry will donate medicines to Direct Relief, a humanitarian aid organization that provides medical assistance to people affected by poverty or emergencies.
Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.
